Wooridul Pharmaceutical Limited (KOSE:A004720) announced a private placement of 32 series unregistered coupon non-guaranteed private bonds with warrants for gross proceeds of KRW 20,000,000,000 on November 11, 2020. The company will also issue warrants exercisable into 1,342,281 shares with an exercise price of KRW 14,900 for 9.12% stake in the company during November 19, 2021 and October 19, 2023. The bond is issued at 2.5% coupon rate, 2.5% yield to maturity rate and will mature on November 19, 2023. The transaction will include participation from new investor Linden Capital L.P , a fund managed by Linden Advisors LP and SC Lowy Financial (HK) Limited for KRW 10,000,000,000 each. The subscription date is November 13, 2020 and the payment date is November 19, 2020. The securities are subjected to hold period of 1 year. The transaction has been approved by the board of directors of the company.